About Us

Sinclair Dunlop

Sinclair Dunlop, M.B.A.


As Managing Partner of Epidarex, Mr. Dunlop leads the review and analysis of Epidarex investment candidates. A former international business and economics analyst with the Center for Strategic & International Studies in Washington, D.C., Mr. Dunlop has private equity and venture capital experience in Europe, the U.S. and Israel. Prior to founding Epidarex, Mr. Dunlop acted as the Director of New Business Ventures of MASA Life Science Ventures after a period as an Associate at New Vantage Group, manager of several early-stage venture capital funds in the Mid-Atlantic region. In May 2000, Mr. Dunlop received his M.B.A. from Columbia Business School where he was the R.C. Kopf British-American Fellow in international business. He also holds an M.A. with Honors in Political Economy from the University of Glasgow and an M.A. in International Relations from the Maxwell School of Citizenship and Public Affairs at Syracuse University. He is a St. Andrews Society of New York Scholar.
Apellis logo
© Apellis Pharmaceuticals 2019.